AN2 Therapeutics, Inc.(ANTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANTX AN2 Therapeutics, Inc.

休市中 07-26 16:00:00 EDT

2.68

+0.04

+1.52%

盘后2.68

+0.000.00%

18:47 EDT

最高2.68	最低2.59	成交量3.90万
今开2.65	昨收2.64	日振幅3.41%
总市值7,994万	流通市值3,109万	总股本2,983万
成交额10.28万	换手率0.34%	流通股本1,160万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANTX","market":"US","secType":"STK","nameCN":"AN2 Therapeutics, Inc.","latestPrice":2.68,"timestamp":1722024000000,"preClose":2.64,"halted":0,"volume":38981,"hourTrading":{"tag":"盘后","latestPrice":2.68,"preClose":2.68,"latestTime":"18:47 EDT","volume":30,"amount":80.06,"timestamp":1722034076718},"delay":0,"floatShares":11600722,"shares":29829040,"eps":-2.520604,"marketStatus":"休市中","marketStatusCode":7,"change":0.04,"latestTime":"07-26 16:00:00 EDT","open":2.65,"high":2.68,"low":2.59,"amount":102826.9352092,"amplitude":0.034091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.520604,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"listingDate":1648180800000,"adjPreClose":2.64,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.64,"preClose":2.64,"latestTime":"08:00 EDT","volume":492,"amount":1298.88,"timestamp":1721995201845},"postHourTrading":{"tag":"盘后","latestPrice":2.68,"preClose":2.68,"latestTime":"18:47 EDT","volume":30,"amount":80.06,"timestamp":1722034076718},"volumeRatio":0.4942236408462102},"requestUrl":"/m/hq/s/ANTX/tweets","defaultTab":"tweets","newsList":[{"id":"2453886063","title":"An2 Therapeutics, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453886063","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453886063?lang=zh_cn&edition=full","pubTime":"2024-07-24 22:49","pubTimestamp":1721832580,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日22时49分，An2 Therapeutics, Inc.股票出现异动，股价急速下跌5.09%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃，换手率分别为7451.44%、1173.07%、615.87%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ，振幅分别为191.54%、99.60%、72.79%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724224940941fa2dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724224940941fa2dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANTX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2452165635","title":"An2 Therapeutics, Inc.盘中异动 急速拉升5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452165635","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452165635?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:56","pubTimestamp":1721228207,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时56分，An2 Therapeutics, Inc.股票出现异动，股价快速上涨5.75%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.25%。其相关个股中，Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Aditxt, Inc.涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为2743.82%、1230.13%、265.80%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Aditxt, Inc.，振幅分别为76.39%、43.75%、31.25%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717225647941f7f03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717225647941f7f03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2448886234","title":"An2 Therapeutics, Inc.盘中异动 早盘急速上涨7.75%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448886234","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448886234?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:30","pubTimestamp":1720013438,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时30分，An2 Therapeutics, Inc.股票出现异动，股价大幅上涨7.75%。截至发稿，该股报2.30美元/股，成交量5.6038万股，换手率0.19%，振幅0.00%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213038aef7c9a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213038aef7c9a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANTX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2435429736","title":"美国研究综述-AN2 Therapeutics、艺康公司、RPM 国际公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2435429736","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435429736?lang=zh_cn&edition=full","pubTime":"2024-05-16 14:53","pubTimestamp":1715842434,"startTime":"0","endTime":"0","summary":"    路透5月16日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 AN2 Therapeutics、艺康和 RPM International。要闻              * AN2 Therapeutics Inc   ：Evercore ISI将目标价从7美元下调至2美元             * Biolife Solutions Inc   ：Maxim Group将目标价从25美元上调至30美元             * Ecolab Inc   ：Evercore ISI将目标价从195美元上调至250美元             * RPM International Inc   ：Evercore ISI 将目标价从 110 美元上调至 130 美元             * Third Harmonic Bio Inc   ：杰富瑞将目标价从8.1美元上调至15美元 以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","SWN","CABA","RPM","FLO","HES","LU0300736062.USD","OLMA","ADI","LU2092937221.SGD","KOD","KOS","ANTX","MOH","DVN","LU1978683503.SGD","BK4512","LU0496367417.USD","NEM","BK4209","LU0889565833.HKD","MANH","RVPH","STWD","LENZ","THRD","LU0868494617.USD","LU1992135472.HKD","GDRX","IGT","JACK","NXT","LU1223083913.SGD","LU1599440770.SGD","EOSE","CE","EMN","TRGP","BK4109","BLFS","EPD","VISL","DT","ASH","ECL","CSCO","SG9999014039.USD","LU1571399168.USD","LU1223082196.USD","AXTA"],"gpt_icon":0},{"id":"2427000946","title":"An2 Therapeutics, Inc.盘中异动 早盘急速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427000946","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427000946?lang=zh_cn&edition=full","pubTime":"2024-04-15 23:16","pubTimestamp":1713194217,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日23时16分，An2 Therapeutics, Inc.股票出现异动，股价急速下跌5.11%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，安皮奥制药、Soligenix, Inc.、Longeveron Inc.涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1376.41%、1101.37%、787.28%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、90.57%、80.04%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152316577a52def7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152316577a52def7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ANTX","BK4007"],"gpt_icon":0},{"id":"2420872113","title":"An2 Therapeutics, Inc.盘中异动 早盘快速上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420872113","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420872113?lang=zh_cn&edition=full","pubTime":"2024-03-20 23:08","pubTimestamp":1710947293,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日23时08分，An2 Therapeutics, Inc.股票出现波动，股价大幅拉升5.54%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320230813791bc1e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320230813791bc1e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2417760416","title":"An2 Therapeutics, Inc.盘中异动 快速拉升5.23%报3.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417760416","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417760416?lang=zh_cn&edition=full","pubTime":"2024-03-07 22:49","pubTimestamp":1709822975,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日22时49分，An2 Therapeutics, Inc.股票出现异动，股价快速拉升5.23%。截至发稿，该股报3.02美元/股，成交量4.8106万股，换手率0.16%，振幅4.53%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.47%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072249367a4a802b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072249367a4a802b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2415253075","title":"An2 Therapeutics, Inc.盘中异动 大幅拉升5.63%报3.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415253075","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415253075?lang=zh_cn&edition=full","pubTime":"2024-02-29 23:10","pubTimestamp":1709219411,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日23时10分，An2 Therapeutics, Inc.股票出现波动，股价急速拉升5.63%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.22%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022923101287e74ead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022923101287e74ead&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2414387205","title":"An2 Therapeutics Inc盘中异动 股价大跌5.11%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414387205","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414387205?lang=zh_cn&edition=full","pubTime":"2024-02-28 04:33","pubTimestamp":1709066022,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日04时33分，An2 Therapeutics Inc股票出现异动，股价快速下跌5.11%。截至发稿，该股报2.97美元/股，成交量64.75万股，换手率2.18%，振幅5.88%。An2 Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.39%。An2 Therapeutics Inc公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240228043342791526d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240228043342791526d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2414468836","title":"An2 Therapeutics Inc盘中异动 股价大涨5.18%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414468836","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414468836?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:22","pubTimestamp":1708960956,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日23时22分，An2 Therapeutics Inc股票出现异动，股价大幅拉升5.18%。截至发稿，该股报3.25美元/股，成交量9.4782万股，换手率0.32%，振幅5.18%。An2 Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Zyversa Therapeutics Inc、Calidi Biotherapeutics Inc、Krystal Biotech Inc涨幅较大，Zyversa Therapeutics Inc、Lixte Biotechnology Holdings  Inc、Ocean Biomedical Inc较为活跃，换手率分别为1343.91%、61.68%、57.65%，振幅较大的相关个股有Zyversa Therapeutics Inc、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Ocean Biomedical Inc，振幅分别为144.82%、62.88%、52.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262322377914b516&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262322377914b516&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2411338359","title":"美国研究综述-An2 Therapeutics、Par Technology、Trimble","url":"https://stock-news.laohu8.com/highlight/detail?id=2411338359","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411338359?lang=zh_cn&edition=full","pubTime":"2024-02-13 15:10","pubTimestamp":1707808204,"startTime":"0","endTime":"0","summary":"    路透社2月13日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 An2 Therapeutics、Par Technology 和 Trimble。公司要闻 * An2 Therapeutics Inc   ：Leerink Partners将其评级从 \"跑赢大盘 \"下调至 \"市场表现\"。* Par Technology Corp   ：Benchmark给予其 \"持有 \"评级 * Trimble Inc   ：Piper Sandler 将其评级从 \"中性 \"上调至 \"增持\"。* Cymabay Therapeutics Inc   ：B. Riley 将目标价从 29 美元上调至 32.5 美元 * Cymabay Therapeutics Inc   ：Jonestrading将其目标价从 \"买入 \"下调至 \"持有\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FANG","PANW","ANTX","LU1721427968.SGD","LU1496350171.SGD","COST","CDNS","GTHX","LU1861559042.SGD","ZI","FOUR","LU0079474960.USD","LU0820561818.USD","MAS","IE00B7SZL793.SGD","DKNG","TRMB","DOCS","BK4020","BIG","RPAY","IIIV","CBAY","RBLX","ROAD","LU1992135399.USD","CRK","LU1861558580.USD","PFG","LU0097036916.USD","VCTR","ALL","WH","STC","CMPO","TDC","PAYO","ANET","BK4135","LU1917777945.USD","WMG","AMCX","SQ","IE00BKVL7J92.USD","BK4551","BK4007","PAR","BK4550","DEI","EHC"],"gpt_icon":0},{"id":"2410405668","title":"嗡嗡声--美国股票走势-Diamondback、Rivian Automotive、BioXcel Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2410405668","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410405668?lang=zh_cn&edition=full","pubTime":"2024-02-12 22:23","pubTimestamp":1707747784,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      2月12日 - 继前一周强劲收盘后，周一美国股指期货表现低迷，市场关注一系列经济数据，这些数据可能会消除降息前景的一些不确定性。美东时间9:01，道指电子盘  下跌0.10%，报38,710点。标准普尔500指数小型股  下跌0.03%，报5,042.25点；纳斯达克100指数小型股  下跌0.05%，报18,029.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIG","NYCB","FANG","BK4127","LU0320765646.SGD","IE00B7SZL793.SGD","ANTX","BK4504","BK4519","LU0310800965.SGD","BK4585","BK4207","BK4129","LU0128525689.USD","SOL","IE00B19Z4B17.USD","BTAI","LU1267930227.SGD","BK4139","BK4099","BK4566","RILY","RIVN","LU0052756011.USD","BK4114","BK4008","IE00BSNM7G36.USD","LU0098860793.USD","BK4555","BK4211","IE00B66KJ199.SGD","IE0031619046.USD","BK4195","BK4007","BK4220","LU1162221912.USD","BK4213","C","BK4588","BK4534","JOBY"],"gpt_icon":0},{"id":"1121920701","title":"盘前 | 关键试验暂停，ANTX暴跌70%；英伟达开盘有望再创新高！","url":"https://stock-news.laohu8.com/highlight/detail?id=1121920701","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1121920701?lang=zh_cn&edition=full","pubTime":"2024-02-12 21:04","pubTimestamp":1707743058,"startTime":"0","endTime":"0","summary":"英伟达进军定制芯片领域，股价有望再创新高，市值直逼$亚马逊$谷歌上周五，美股AI总龙头英伟达收高3.58%，再创历史新高。英伟达据传将进军定制芯片市场，进一步巩固其在AI芯片方面的领导地位，甚至有望内部“再造一个Arm”。受此消息刺激英伟达股价再创新高，市值逼近亚马逊和谷歌。截至发稿，英伟达盘前再涨近1%，开盘有望再创新高。AN2 Therapeutics盘前暴跌70%，公司表示将暂停Epetraborole试验的3期招募，理由是其疗效可能低于预期。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585",".DJI","IE00BMPRXR70.SGD","LU0082616367.USD","LU0820561909.HKD","LU0642271901.SGD","LU0719512351.SGD","LU0061474960.USD","IE00B19Z9505.USD","IE0004445239.USD","BK4567",".IXIC","IE00BJJMRY28.SGD","ANTX","NVDA","IE00BMPRXN33.USD","LU0053666078.USD",".SPX","BK4579","BK4534","BK4587","BK4533","LU0353189680.USD"],"gpt_icon":1},{"id":"2410841386","title":"BUZZ-AN2 Therapeutics大跌，原因是共同暂停肺病研究的招生工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2410841386","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410841386?lang=zh_cn&edition=full","pubTime":"2024-02-12 20:40","pubTimestamp":1707741643,"startTime":"0","endTime":"0","summary":"    2月12日 - ** 药物开发商AN2 Therapeutics   股价盘前下跌71.5%，至5.75美元** 该公司已决定 ，在进一步的数据审查之前，自愿暂停一项测试其治疗一种肺部细菌感染的实验性药物的中后期研究的后期部分的注册工作。** 截至上次收盘，股价在过去 12 个月中上涨了约 40","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BUZZ","ANTX"],"gpt_icon":0},{"id":"2410624846","title":"AN2 Therapeutics 暂停肺病研究注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2410624846","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410624846?lang=zh_cn&edition=full","pubTime":"2024-02-12 19:54","pubTimestamp":1707738887,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社2月12日 - AN2 Therapeutics公司  周一表示，将暂停一项测试其治疗一种肺部细菌感染的实验性药物的中后期研究的进一步注册，理由是其疗效可能低于预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2408385629","title":"An2 Therapeutics Inc盘中异动 快速上涨5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408385629","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2408385629?lang=zh_cn&edition=full","pubTime":"2024-02-02 23:34","pubTimestamp":1706888090,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日23时34分，An2 Therapeutics Inc股票出现波动，股价大幅上涨5.72%。截至发稿，该股报21.08美元/股，成交量6708股，换手率0.02%，振幅4.26%。An2 Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.62%。An2 Therapeutics Inc公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202233450790ea581&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202233450790ea581&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANTX","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.an2therapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0394},{"period":"1month","weight":0.2701},{"period":"3month","weight":0.1552},{"period":"6month","weight":-0.8626},{"period":"1year","weight":-0.6724},{"period":"ytd","weight":-0.8692}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0712},{"period":"6month","weight":0.117},{"period":"1year","weight":0.2032},{"period":"ytd","weight":0.1454}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AN2 Therapeutics, Inc.于2017年2月在特拉华州注册成立。他们是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的治疗方法。他们的核心技术方法基于将硼化学用于他们的药物研发计划。他们正在开发用于治疗NTM肺病的口服epetraborole，这是一种罕见的慢性进行性传染病，由称为分枝杆菌的细菌引起，可导致不可逆的肺损伤并可能致命。","exchange":"NASDAQ","name":"AN2 Therapeutics, Inc.","nameEN":"AN2 Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AN2 Therapeutics, Inc.(ANTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供AN2 Therapeutics, Inc.(ANTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"AN2 Therapeutics, Inc.,ANTX,AN2 Therapeutics, Inc.股票,AN2 Therapeutics, Inc.股票老虎,AN2 Therapeutics, Inc.股票老虎国际,AN2 Therapeutics, Inc.行情,AN2 Therapeutics, Inc.股票行情,AN2 Therapeutics, Inc.股价,AN2 Therapeutics, Inc.股市,AN2 Therapeutics, Inc.股票价格,AN2 Therapeutics, Inc.股票交易,AN2 Therapeutics, Inc.股票购买,AN2 Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AN2 Therapeutics, Inc.(ANTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供AN2 Therapeutics, Inc.(ANTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}